PALATIN TECHNOLOGIES, INC. Revenue from Contract with Customer, Excluding Assessed Tax
PALATIN TECHNOLOGIES, INC. (PTN) reported Revenue from Contract with Customer, Excluding Assessed Tax of $3.92 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $3.92M.
- PALATIN TECHNOLOGIES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $116.04K.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month |
|---|---|---|---|
| 2026-03-31 | $3.92M 10-Q · filed 2026-05-13 | $4.04M derived: sum of 2 quarters · filed 2026-05-13 | $12.88M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $116.04K 10-Q · filed 2026-02-17 | $8.96M 10-Q · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |